Omega Fund Management, Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$163.1M
Q ending 2026-03-31
Prior quarter
$286.5M
Q ending 2025-12-31
Change
-43.1% QoQ · -3.7% YoY
Positions
10
reported holdings
Largest positions
All 10 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Bicara Therapeutics Inc. | BCAX | Shares | $47.6M | 2.4M |
| Nuvation Bio Inc. | NUVB | Shares | $34.7M | 8.1M |
| Bridgebio Oncology Therapeutics In | BBOT | Shares | $29.4M | 3.3M |
| Kestra Med Technologies Ltd | Shares | $20.4M | 1.0M | |
| Beta Bionics Inc. | BBNX | Shares | $13.2M | 1.3M |
| Engene Holdings Inc. | Shares | $6.0M | 876K | |
| Alumis Inc. | ALMS | Shares | $5.3M | 241K |
| Sana Biotechnology, Inc. | SANA | Shares | $2.4M | 844K |
| Imagenebio, Inc. | IMA | Shares | $2.3M | 455K |
| Replimune Group | REPL | Shares | $1.9M | 249K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.